Investing.com -- ProPhase Labs Inc (NASDAQ:PRPH)股票在该公司宣布获得其基于生物标志物的系统关键专利后飙升38%,该系统用于评估巴雷特食管和食管腺癌的进展风险。 美国专利商标局颁发了美国专利号12379378-B2,用于该公司支撑其BE-Smart™分子诊断测试的方法。这一专利保护紧随ProPhase最近宣布其BE-Smart™测试在检测公司生物...
Source LinkInvesting.com -- ProPhase Labs Inc (NASDAQ:PRPH)股票在该公司宣布获得其基于生物标志物的系统关键专利后飙升38%,该系统用于评估巴雷特食管和食管腺癌的进展风险。 美国专利商标局颁发了美国专利号12379378-B2,用于该公司支撑其BE-Smart™分子诊断测试的方法。这一专利保护紧随ProPhase最近宣布其BE-Smart™测试在检测公司生物...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.